Internal Medicine · Lufkin, TX
NPI
1518073121
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1111 W Frank Ave, Suite 100
Lufkin, TX, 75904
Phone (936) 639-2244
Groups this clinician bills Medicare through
Medicare paid, 2024
$294K
5,224 services
Medicare patients, 2024
416
Average age 79
Drug cost, 2024
$828K
8,419 prescriptions
Company payments, 2025
$600
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Richard E Roby Jr. was code 99490 (chronic, principal, and transitional care management), 1,586 times for 357 patients. In total Richard E Roby Jr. billed 5,224 services in 36 codes, and Medicare paid $294K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-06-08.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99490 Chronic, Principal, and Transitional Care Management | Office | 1,586 | 357 | $46.60 | $74K |
| 99214 Office E&M - Established | Office | 1,182 | 373 | $87.35 | $103K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,073 | 334 | $12.21 | $13K |
| 99213 Office E&M - Established | Office | 275 | 180 | $60.36 | $17K |
| 99497 Care Management/Coordination | Office | 191 | 190 | $78.01 | $15K |
| 99215 Office E&M - Established | Office | 178 | 118 | $135.93 | $24K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 175 | 175 | $125.93 | $22K |
| 83036 Blood Count | Office | 108 | 66 | $9.52 | $1,028 |
| G0008 Administration of influenza virus vaccine | Office | 82 | 81 | $29.40 | $2,411 |
| 90653 Vaccine Product | Office | 77 | 77 | $58.34 | $4,492 |
| 93000 Electrocardiogram | Office | 50 | 46 | $9.07 | $454 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 36 | 33 | $34.64 | $1,247 |
| G0506 Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | Office | 30 | 30 | $45.53 | $1,366 |
| 99204 Office E&M - New | Office | 16 | 16 | $122.28 | $1,956 |
| 90677 Vaccine Product | Office | 14 | 14 | $292.08 | $4,089 |
By year: 2022 $307K for 4,621 services; 2023 $290K for 4,552 services; 2024 $294K for 5,224 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 108 | 66 | $9.52 | $1,028 |
Medicare prescription drug claims, 2024
In 2024, the drug Richard E Roby Jr. prescribed most often to Medicare patients was Levothyroxine Sodium, with 499 prescriptions and refills. In total Richard E Roby Jr. wrote 8,419 Medicare prescriptions that cost $828K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 499 | 1,292 | 126 | $6,579 |
| Atorvastatin Calcium Generic | 422 | 1,144 | 121 | $3,951 |
| Amlodipine Besylate Generic | 387 | 994 | 108 | $3,181 |
| Losartan Potassium Generic | 296 | 777 | 82 | $3,588 |
| Lisinopril Generic | 266 | 720 | 74 | $3,016 |
| Pantoprazole Sodium Generic | 232 | 541 | 56 | $2,877 |
| Gabapentin Generic | 228 | 479 | 62 | $4,428 |
| Rosuvastatin Calcium Generic | 219 | 584 | 72 | $2,982 |
| Eliquis Apixaban | 199 | 287 | 36 | $148K |
| Metformin Hcl Generic | 196 | 500 | 54 | $2,016 |
| Furosemide Generic | 195 | 334 | 45 | $846 |
| Duloxetine Hcl Generic | 189 | 447 | 55 | $5,491 |
| Simvastatin Generic | 183 | 485 | 47 | $1,822 |
| Potassium Chloride Generic | 182 | 354 | 49 | $4,850 |
| Hydrochlorothiazide Generic | 181 | 443 | 51 | $985 |
Brand drugs: 1,141 claims; generic drugs: 7,217 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Richard E Roby Jr. $600 ($600 in general payments such as food, travel and fees) from 13 companies. The largest payer was Novo Nordisk Inc with $100.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 4 | $100 |
| Dexcom, Inc. DXCM | 4 | $86.85 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $72.81 |
| Amgen Inc. AMGN | 5 | $70.78 |
| Sumitomo Pharma America, Inc. 4506.T | 3 | $68.48 |
| Merck Sharp & Dohme LLC MRK | 2 | $46.22 |
| Viatris Specialty LLC | 1 | $30.7 |
| Abiomed JNJ | 1 | $26.61 |
| Abbvie Inc. ABBV | 1 | $23.53 |
| Exact Sciences Corporation EXAS | 1 | $20.9 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.